The hepatoprotecting action of methylthiouracil and carbimazol on the evolution of experimental chronic hepatitis.
D000818:Animals; D002231:Carbimazole / Q000627:therapeutic use*; D002252:Carbon Tetrachloride Poisoning / Q000188:drug therapy* / Q000201:enzymology; D005230:Fatty Acids, Nonesterified / Q000032:analysis; D005947:Glucose / Q000032:analysis; D005952:Glucose-6-Phosphatase / Q000032:analysis; D008099:Liver / Q000032:analysis; D008106:Liver Cirrhosis, Experimental / Q000188:drug therapy* / Q000201:enzymology; D008297:Male; D008779:Methylthiouracil / Q000627:therapeutic use*; D010744:Phosphoric Monoester Hydrolases / Q000032:analysis; D051381:Rats; D012964:Sodium / Q000032:analysis
D005230:Fatty Acids, Nonesterified; D002231:Carbimazole; D012964:Sodium; D010744:Phosphoric Monoester Hydrolases; D005952:Glucose-6-Phosphatase; D005947:Glucose; D008779:Methylthiouracil